Form 8-K - Current report:
SEC Accession No. 0001104659-25-027762
Filing Date
2025-03-25
Accepted
2025-03-25 16:02:46
Documents
67
Period of Report
2025-03-25
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm258849d2_8k.htm   iXBRL 8-K 29645
2 EXHIBIT 99.1 tm258849d2_ex99-1.htm EX-99.1 77617
7 GRAPHIC tm258849d2_ex99-1img001.jpg GRAPHIC 200664
8 GRAPHIC tm258849d2_ex99-1img002.jpg GRAPHIC 481113
9 GRAPHIC tm258849d2_ex99-1img003.jpg GRAPHIC 132348
10 GRAPHIC tm258849d2_ex99-1img004.jpg GRAPHIC 174760
11 GRAPHIC tm258849d2_ex99-1img005.jpg GRAPHIC 188324
12 GRAPHIC tm258849d2_ex99-1img006.jpg GRAPHIC 207568
13 GRAPHIC tm258849d2_ex99-1img007.jpg GRAPHIC 117856
14 GRAPHIC tm258849d2_ex99-1img008.jpg GRAPHIC 193965
15 GRAPHIC tm258849d2_ex99-1img009.jpg GRAPHIC 109175
16 GRAPHIC tm258849d2_ex99-1img010.jpg GRAPHIC 150355
17 GRAPHIC tm258849d2_ex99-1img011.jpg GRAPHIC 162120
18 GRAPHIC tm258849d2_ex99-1img012.jpg GRAPHIC 222437
19 GRAPHIC tm258849d2_ex99-1img013.jpg GRAPHIC 204350
20 GRAPHIC tm258849d2_ex99-1img014.jpg GRAPHIC 171847
21 GRAPHIC tm258849d2_ex99-1img015.jpg GRAPHIC 110934
22 GRAPHIC tm258849d2_ex99-1img016.jpg GRAPHIC 194614
23 GRAPHIC tm258849d2_ex99-1img017.jpg GRAPHIC 109886
24 GRAPHIC tm258849d2_ex99-1img018.jpg GRAPHIC 183498
25 GRAPHIC tm258849d2_ex99-1img019.jpg GRAPHIC 142976
26 GRAPHIC tm258849d2_ex99-1img020.jpg GRAPHIC 150523
27 GRAPHIC tm258849d2_ex99-1img021.jpg GRAPHIC 178165
28 GRAPHIC tm258849d2_ex99-1img022.jpg GRAPHIC 103959
29 GRAPHIC tm258849d2_ex99-1img023.jpg GRAPHIC 157888
30 GRAPHIC tm258849d2_ex99-1img024.jpg GRAPHIC 137120
31 GRAPHIC tm258849d2_ex99-1img025.jpg GRAPHIC 210082
32 GRAPHIC tm258849d2_ex99-1img026.jpg GRAPHIC 167817
33 GRAPHIC tm258849d2_ex99-1img027.jpg GRAPHIC 184981
34 GRAPHIC tm258849d2_ex99-1img028.jpg GRAPHIC 167619
35 GRAPHIC tm258849d2_ex99-1img029.jpg GRAPHIC 162229
36 GRAPHIC tm258849d2_ex99-1img030.jpg GRAPHIC 103124
37 GRAPHIC tm258849d2_ex99-1img031.jpg GRAPHIC 157605
38 GRAPHIC tm258849d2_ex99-1img032.jpg GRAPHIC 153754
39 GRAPHIC tm258849d2_ex99-1img033.jpg GRAPHIC 160939
40 GRAPHIC tm258849d2_ex99-1img034.jpg GRAPHIC 93201
41 GRAPHIC tm258849d2_ex99-1img035.jpg GRAPHIC 113498
42 GRAPHIC tm258849d2_ex99-1img036.jpg GRAPHIC 161921
43 GRAPHIC tm258849d2_ex99-1img037.jpg GRAPHIC 140873
44 GRAPHIC tm258849d2_ex99-1img038.jpg GRAPHIC 162458
45 GRAPHIC tm258849d2_ex99-1img039.jpg GRAPHIC 86838
46 GRAPHIC tm258849d2_ex99-1img040.jpg GRAPHIC 185505
47 GRAPHIC tm258849d2_ex99-1img041.jpg GRAPHIC 141831
48 GRAPHIC tm258849d2_ex99-1img042.jpg GRAPHIC 135980
49 GRAPHIC tm258849d2_ex99-1img043.jpg GRAPHIC 105425
50 GRAPHIC tm258849d2_ex99-1img044.jpg GRAPHIC 164264
51 GRAPHIC tm258849d2_ex99-1img045.jpg GRAPHIC 130331
52 GRAPHIC tm258849d2_ex99-1img046.jpg GRAPHIC 171163
53 GRAPHIC tm258849d2_ex99-1img047.jpg GRAPHIC 99800
54 GRAPHIC tm258849d2_ex99-1img048.jpg GRAPHIC 123008
55 GRAPHIC tm258849d2_ex99-1img049.jpg GRAPHIC 170676
56 GRAPHIC tm258849d2_ex99-1img050.jpg GRAPHIC 148094
57 GRAPHIC tm258849d2_ex99-1img051.jpg GRAPHIC 97519
58 GRAPHIC tm258849d2_ex99-1img052.jpg GRAPHIC 61934
  Complete submission text file 0001104659-25-027762.txt   11539964

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA huma-20250325.xsd EX-101.SCH 3680
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE huma-20250325_def.xml EX-101.DEF 26749
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE huma-20250325_lab.xml EX-101.LAB 37571
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE huma-20250325_pre.xml EX-101.PRE 25373
69 EXTRACTED XBRL INSTANCE DOCUMENT tm258849d2_8k_htm.xml XML 5873
Mailing Address 2525 EAST NORTH CAROLINA HIGHWAY 54 DURHAM NC 27713
Business Address 2525 EAST NORTH CAROLINA HIGHWAY 54 DURHAM NC 27713 919-313-9633
Humacyte, Inc. (Filer) CIK: 0001818382 (see all company filings)

EIN.: 851763759 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39532 | Film No.: 25768220
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)